Developing Orders for Infectious Disease Therapeutics and Vaccine Projects
First written in FY2020. 1 of 3 entries say "Restated". Latest entry: FY2021-Q2.
The whole theme swung hardest in 2024: 1 of 7 companies on the "Worse" side.
2 other companies' latest entry also says "Advanced".
- FY2021-Q2AdvancedAnnual report
「We will continue to support the development of effective treatments and preventive measures for COVID-19, including physician-initiated clinical trials conducted under an agreement with Kitasato Institute for the purpose of adding an indication for ivermectin against COVID-19. Through these efforts, we will contribute to infection prevention, effective treatment for the early recovery of patients, and the maintenance of healthcare systems, thereby fulfilling our social mission.」
The company stated that it had entered into an agreement with Kitasato Institute for a physician-initiated clinical trial seeking to add an indication for ivermectin, giving concrete form to its support for the development of treatments and preventive measures for infectious diseases. - FY2021-Q1RestatedAnnual report
「There are signs of recovery in inquiries regarding new projects in various countries, including multiple inquiries regarding COVID-19 treatment projects in the United States. As the Group works together to win these new projects, we expect performance to gradually improve going forward.」
The company stated that inquiries regarding new projects, including COVID-19 treatment projects, were showing signs of recovery in various countries and reaffirmed its policy of pursuing these projects. However, the inquiries remain at the discussion stage rather than representing completed orders. - FY2020First statedAnnual report
「In anticipation of the timing of economic reopening in various countries following the COVID-19 pandemic, we are also conducting business development in each country through remote sales activities using the web and other means to pursue new orders, including COVID-19 vaccines and treatments, and have received inquiries regarding multiple projects.」
The company is pursuing new orders in various countries, including vaccines and treatments, through remote sales using the web, and has received inquiries regarding multiple projects.